CVE-2013-2165

Description

ResourceBuilderImpl.java in the RichFaces 3.x through 5.x implementation in Red Hat JBoss Web Framework Kit before 2.3.0, Red Hat JBoss Web Platform through 5.2.0, Red Hat JBoss Enterprise Application Platform through 4.3.0 CP10 and 5.x through 5.2.0, Red Hat JBoss BRMS through 5.3.1, Red Hat JBoss SOA Platform through 4.3.0 CP05 and 5.x through 5.3.1, Red Hat JBoss Portal through 4.3 CP07 and 5.x through 5.2.2, and Red Hat JBoss Operations Network through 2.4.2 and 3.x through 3.1.2 does not restrict the classes for which deserialization methods can be called, which allows remote attackers to execute arbitrary code via crafted serialized data.

Category

7.5
CVSS
Severity: High
CVSS 2.0 •
EPSS 34.14% Top 5%
Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory redhat.com
Affected: n/a n/a
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2013-2165?
CVE-2013-2165 has been scored as a high severity vulnerability.
How to fix CVE-2013-2165?
To fix CVE-2013-2165, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2013-2165 being actively exploited in the wild?
It is possible that CVE-2013-2165 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~34% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.